ID

30046

Descripción

Impact of MK-0954A on Uric Acid in the Management of Hypertension (MK-0954A-366); ODM derived from: https://clinicaltrials.gov/show/NCT01368185

Link

https://clinicaltrials.gov/show/NCT01368185

Palabras clave

Versiones (1)
  1. 5/5/18 5/5/18 -
Titular de derechos de autor

See clinicaltrials.gov

Subido en

5 de mayo de 2018

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Hypertension NCT01368185

Inglés

Eligibility Hypertension NCT01368185

1 formularios  
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
participant was >20 years and <75 years of age on the index date (i.e., the date of initiating mk-0954a therapy)
Descripción

Age

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0001779
diagnosed with hypertension and had received mk-0954a 50/12.5 mg for at least 3 months
Descripción

Hypertensive disease | Losartan Potassium

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0020538
UMLS CUI [2]
C0700492
had at least one serum uric acid measurements at baseline and one at 3 months after using mk-0954a 50/12.5 mg
Descripción

Serum uric acid measurement Quantity | Status post Use of Losartan Potassium

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0455272
UMLS CUI [1,2]
C1265611
UMLS CUI [2,1]
C0231290
UMLS CUI [2,2]
C1524063
UMLS CUI [2,3]
C0700492
had the following records documented in the chart during the data collection period:
Descripción

Records Documented

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0034869
UMLS CUI [1,2]
C1301725
medical history and co-morbidities (if available)
Descripción

Medical History | Comorbidity

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0262926
UMLS CUI [2]
C0009488
sitting blood pressure, serum uric acid, lipid profile test results before and after using mk-0954a 50/12.5 mg
Descripción

Sitting blood pressure | Serum uric acid measurement | Lipid profile test

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0580946
UMLS CUI [2]
C0455272
UMLS CUI [3]
C0850354
serum electrolytes, serum creatinine, and pre-meal sugar (if available)
Descripción

Electrolytes measurement, serum | Creatinine measurement, serum | Sugar pre-meal

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0587355
UMLS CUI [2]
C0201976
UMLS CUI [3,1]
C0007004
UMLS CUI [3,2]
C1546096
prescription information of all antihypertensive regimens
Descripción

Prescription document Antihypertensive therapy

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1521941
UMLS CUI [1,2]
C0585941
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
had been treated with diuretic or angiotensin-receptor blockers (arbs) 2 weeks before initiated treatment with mk-0954a 50/12.5 mg
Descripción

Diuretics | Angiotensin II receptor antagonist

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0012798
UMLS CUI [2]
C0521942
serum creatinine >2 mg/dl
Descripción

Creatinine measurement, serum

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0201976
Volver a la parte superior de la página

Similar models

Eligibility Hypertension NCT01368185

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
Age
Item
participant was >20 years and <75 years of age on the index date (i.e., the date of initiating mk-0954a therapy)
boolean
C0001779 (UMLS CUI [1])
Hypertensive disease | Losartan Potassium
Item
diagnosed with hypertension and had received mk-0954a 50/12.5 mg for at least 3 months
boolean
C0020538 (UMLS CUI [1])
C0700492 (UMLS CUI [2])
Serum uric acid measurement Quantity | Status post Use of Losartan Potassium
Item
had at least one serum uric acid measurements at baseline and one at 3 months after using mk-0954a 50/12.5 mg
boolean
C0455272 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
C0231290 (UMLS CUI [2,1])
C1524063 (UMLS CUI [2,2])
C0700492 (UMLS CUI [2,3])
Records Documented
Item
had the following records documented in the chart during the data collection period:
boolean
C0034869 (UMLS CUI [1,1])
C1301725 (UMLS CUI [1,2])
Medical History | Comorbidity
Item
medical history and co-morbidities (if available)
boolean
C0262926 (UMLS CUI [1])
C0009488 (UMLS CUI [2])
Sitting blood pressure | Serum uric acid measurement | Lipid profile test
Item
sitting blood pressure, serum uric acid, lipid profile test results before and after using mk-0954a 50/12.5 mg
boolean
C0580946 (UMLS CUI [1])
C0455272 (UMLS CUI [2])
C0850354 (UMLS CUI [3])
Electrolytes measurement, serum | Creatinine measurement, serum | Sugar pre-meal
Item
serum electrolytes, serum creatinine, and pre-meal sugar (if available)
boolean
C0587355 (UMLS CUI [1])
C0201976 (UMLS CUI [2])
C0007004 (UMLS CUI [3,1])
C1546096 (UMLS CUI [3,2])
Prescription document Antihypertensive therapy
Item
prescription information of all antihypertensive regimens
boolean
C1521941 (UMLS CUI [1,1])
C0585941 (UMLS CUI [1,2])
Item Group
C0680251 (UMLS CUI)
Diuretics | Angiotensin II receptor antagonist
Item
had been treated with diuretic or angiotensin-receptor blockers (arbs) 2 weeks before initiated treatment with mk-0954a 50/12.5 mg
boolean
C0012798 (UMLS CUI [1])
C0521942 (UMLS CUI [2])
Creatinine measurement, serum
Item
serum creatinine >2 mg/dl
boolean
C0201976 (UMLS CUI [1])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial